Literature DB >> 7075026

Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis.

J Egido, R Blasco, J Sancho, L Lozano, M Sanchez-Crespo, L Hernando.   

Abstract

Recently we have described the existence of high levels of polymeric IgA, partially as immune complexes, in the serum and kidney from patients with IgA mesangial glomerulonephritis. As these patients often have macroscopic haematuria, following upper respiratory tract infections, our working hypothesis in this paper was that circulating lymphocytes from secretory tissues after viral stimulus could produce in these patients a large amount of polymeric IgA. To test it, peripheral blood lymphocytes (PBL) from patients and controls were cultured for seven days in the presence or absence of pokeweed mitogen (PWM). In cell culture supernatants immunoglobulin synthesis was measured by RIA and the proportion of polymeric and monomeric IgA was determined on Ultrogel Ac A22 column. There was no difference in spontaneous production of immunoglobulins between patients and controls. On the contrary, the IgA synthetized by PWM-stimulated PBL was significantly higher in patients than in controls. The percentages of IgA with molecular weight between 600,000 and 250,000 after supernate fractionation were significantly higher in patients than in controls. The true nature of polymeric IgA was confirmed by their ability to bind secretory component, the existence of covalent structures, and the decrease of the larger forms of IgA after reduction and alkylation. The percentage of IgA producing cells binding secretory component was significantly higher in patients than in controls (69 +/- 21 versus 44 +/- 27) after seven days of culture. IgM and IgG produced in patient culture were similar to controls. These results show that mitogen stimulated PBL from patients with Berger's disease synthetized a large amount of true polymeric IgA. It is suggested that a similar situation could occur in vivo after viral of other stimuli.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075026      PMCID: PMC1536548     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Recurrence of mesangial deposition of IgA after renal transplantation.

Authors:  J Berger; H Yaneva; B Nabarra; C Barbanel
Journal:  Kidney Int       Date:  1975-04       Impact factor: 10.612

2.  IgA nephropathy.

Authors:  R C McCoy; C R Abramowsky; C C Tisher
Journal:  Am J Pathol       Date:  1974-07       Impact factor: 4.307

3.  Two types of IgA immunocytes in man.

Authors:  P Brandtzaeg
Journal:  Nat New Biol       Date:  1973-05-30

4.  Characteristics of SC-Ig complexes formed in vitro.

Authors:  P Brandtzaeg
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

5.  The origin of monomeric and polymeric forms of IgA in man.

Authors:  J Radl; H R Schuit; J Mestecky; W Hijmans
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

6.  An immunofluorescence study on intracellular immunoglobulins in human bone marrow cells.

Authors:  W Hijmans; H R Schuit; E Hulsing-Hesselink
Journal:  Ann N Y Acad Sci       Date:  1971-06-21       Impact factor: 5.691

7.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

8.  Studies on J chain and binding site for secretory component in circulating human B cells. II. The cytoplasm.

Authors:  P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  The secretory immune system and renal disease.

Authors:  R S Dobrin; F E Knudson; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

10.  IgA and glomerular disease.

Authors:  J A Whitworth; S Leibowitz; M C Kennedy; J S Cameron; C Chantler
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975

View more
  16 in total

1.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

Review 2.  IgA nephropathy.

Authors:  M C Béné; G Faure
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Antibodies to viruses of the herpes group in glomerulonephritis of membranous, membranoproliferative and IgA types.

Authors:  M Uj; G Szücs; J Nagy; C Trinn
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

4.  IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease).

Authors:  A Fornasieri; R A Sinico; P Maldifassi; P Bernasconi; M Vegni; G D'Amico
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-11

5.  Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes.

Authors:  J Sancho; J Egido; F Rivera; L Hernando
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

6.  Immunological studies in a familial IgA nephropathy.

Authors:  J Egido; R Blasco; J Sancho; L Lozano; V Gutierrez-Millet
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

7.  Systemic immune response after mucosal immunization in patients with IgA nephropathy.

Authors:  F B Waldo
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

8.  IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  R Coppo; B Basolo; G Piccoli; G Mazzucco; M R Bulzomì; D Roccatello; M De Marchi; A O Carbonara; G Barbiano di Belgiojoso
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Deposition of polymeric IgA1 in idiopathic mesangial IgA-glomerulonephritis.

Authors:  R Waldherr; H P Seelig; M Rambausek; K Andrassy; E Ritz
Journal:  Klin Wochenschr       Date:  1983-09-15

10.  Immunoregulation in glomerulonephritis, Henoch--Schonlein purpura and lupus nephritis.

Authors:  K M Bannister; P A Drew; A R Clarkson; A J Woodroffe
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.